Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |